Skip to main content
Back to Wellington Management

Wellington Management's Genetics Portfolio

Browse 10 Genetics companies funded by Wellington Management. See funding amounts, founder contacts, and investment details.

Genetics Companies
10
Total Funding in Genetics
$1.1B

Genetics Portfolio Companies (10)

Export
BiotechnologyGeneticsHealth CareHealth DiagnosticsMedical DeviceOncology

Strata Oncology is a precision oncology company dedicated to transforming cancer care.

Ann Arbor, United States
July 2021
$90.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth DiagnosticsLife Science

Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.

San Diego, United States
June 2026
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyEmergency MedicineGeneticsHealth CareMedical

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Boston, United States
June 2024
$100.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.

Cambridge, United States
June 2026
$50.0M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth Care

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

Cambridge, United States
March 2023
$76.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyGeneticsIndustrial AutomationInnovation ManagementLife ScienceMachine LearningSoftware

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

Redwood City, United States
February 2022
$200.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareLife Science

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Cambridge, United States
January 2024
$100.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsMedicalTherapeutics

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

South San Francisco, United States
December 2021
$300.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsLife Science

Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.

Boston, United States
November 2023
$143.8M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth Diagnostics

Nightstar is biopharmaceutical company, focused on developing gene therapies for retinal dystrophies.

London, United Kingdom
June 2017
$45.0M
Series C

Founder Contacts

30,000+ verified contacts

Explore Wellington Management's Full Portfolio

View all companies funded by Wellington Management across every industry and funding stage.

View Full Wellington Management Portfolio